Examining global and gender disparities in high-impact evidence synthesis on lung cancer: A 2000-2024 analysis of Cochrane Library.

Authors

null

Vivek Bhat

St. John's Medical College, Bangalore, India

Vivek Bhat , Shreyas S Bellur , Abhishek Kumar , Sharanya Kaushik , Ahmad Ozair , Harneet Kaur Walia , Manmeet Singh Ahluwalia

Organizations

St. John's Medical College, Bangalore, India, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, King George's Medical University, Lucknow, India, Bangalore Medical College & Research Institute, Bangalore, India, John Hopkins University, Baltimore, MD, Miami Cardiac & Vascular Institute, Baptist Health South Florida, Miami, FL

Research Funding

No funding sources reported

Background: Most cancer-related deaths occur in low-middle-income countries (LMICs), yet LMICs are underrepresented in global oncology research. Women have also historically been underrepresented in clinical literature. High-impact evidence synthesis influences guidelines and practice worldwide, so equitable authorship can ensure that issues presented are applicable globally. The Cochrane Library is a repository of high-impact systematic reviews that can be authored from all over the world. So, we aimed to analyze the representation of LMICs and women in the authorship of lung-cancer-related Cochrane Reviews. Methods: From the topic 'Lung and Airways' in the Cochrane Library, we included all studies related to lung cancer, published till February 2, 2024. We extracted the authors’ national affiliations, categorizing them into LMICs and non-LMICs based on the 2023 World Bank income classifications. Collaboratives/ groups were considered as a single entity. Following this, we manually captured at least one webpage for each author showing their gender or gender pronouns. For authors whose gender could not be determined via manual search, we used Gender-API, an artificial intelligence-based software, to determine their gender based on their name and country. Authors with < 90% certainty of gender on Gender-API were categorized as unknown. Results: We included 42 reviews that had 233 authors, including three group authors. United Kingdom (22.32%; n = 52/233), followed by Australia (16.31%; n = 38/233), Spain (13.3%; n = 31/233), China (9.01%; n = 21/233) and France (6.87%; n = 16/233) were the most represented countries. There were no authors from LMICs. Manually, we ascertained gender for 85.04% (n = 194/228) of authors, and overall, for 94.74% (n = 216/228). Women constituted 42.6% (n = 92/216) of all authors. They were, however, better represented as first authors (50%; n = 19/38) and corresponding authors (54.05%; n = 20/37). Conclusions: Despite suffering the brunt of cancer, LMICs had no representation in lung-cancer-related Cochrane reviews. While authorship had a male preponderance overall, women were well represented as first and corresponding authors. Addressing authorship disparities in global oncology literature, via mentorship and capacity building, can improve its applicability and utilization.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2024 ASCO Annual Meeting

Session Type

Publication Only

Session Title

Publication Only: Quality Care/Health Services Research

Track

Care Delivery and Quality Care

Sub Track

Clinical Research Design

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr e23021)

DOI

10.1200/JCO.2024.42.16_suppl.e23021

Abstract #

e23021

Abstract Disclosures

Similar Abstracts

First Author: Kyle Edwards

Abstract

2022 ASCO Annual Meeting

Examination of speakership gender disparity at an international oncology conference.

First Author: Jessica Caro

Abstract

2022 ASCO Quality Care Symposium

Racial and gender disparities in metastatic lung and bronchial cancer (LC) across the United States.

First Author: Devashish Desai

Abstract

2021 ASCO Annual Meeting

Authorship gender equity in global oncology publications.

First Author: Paula Hornstein